Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122618796 | 12261879 | 6 | F | 20160321 | 20160721 | 20160413 | 20160803 | EXP | GB-TEVA-649814ACC | TEVA | 66.00 | YR | M | Y | 0.00000 | 20160804 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122618796 | 12261879 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | U | U | 74656 | 156 | MG | |||||||
| 122618796 | 12261879 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | U | U | 74656 | 156 | MG | |||||||
| 122618796 | 12261879 | 3 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | U | 0 | 675 | MG | |||||||
| 122618796 | 12261879 | 4 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | U | 0 | 675 | MG | |||||||
| 122618796 | 12261879 | 5 | SS | DENOSUMAB | DENOSUMAB | 1 | Unknown | U | U | 0 | 120 | MG | |||||||
| 122618796 | 12261879 | 6 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | U | U | 0 | 6 | MG | |||||||
| 122618796 | 12261879 | 7 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | U | U | 0 | |||||||||
| 122618796 | 12261879 | 8 | SS | PEMETREXED | PEMETREXED | 1 | Unknown | U | U | 0 | 1050 | MG | |||||||
| 122618796 | 12261879 | 9 | SS | APREPITANT. | APREPITANT | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122618796 | 12261879 | 1 | Product used for unknown indication |
| 122618796 | 12261879 | 3 | Product used for unknown indication |
| 122618796 | 12261879 | 5 | Product used for unknown indication |
| 122618796 | 12261879 | 6 | Product used for unknown indication |
| 122618796 | 12261879 | 8 | Product used for unknown indication |
| 122618796 | 12261879 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122618796 | 12261879 | HO |
| 122618796 | 12261879 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122618796 | 12261879 | Alopecia | |
| 122618796 | 12261879 | Contusion | |
| 122618796 | 12261879 | Cough | |
| 122618796 | 12261879 | Decreased appetite | |
| 122618796 | 12261879 | Dehydration | |
| 122618796 | 12261879 | Dizziness | |
| 122618796 | 12261879 | Dysgeusia | |
| 122618796 | 12261879 | Dyspnoea | |
| 122618796 | 12261879 | Epistaxis | |
| 122618796 | 12261879 | Fall | |
| 122618796 | 12261879 | Fatigue | |
| 122618796 | 12261879 | Flushing | |
| 122618796 | 12261879 | Headache | |
| 122618796 | 12261879 | Joint swelling | |
| 122618796 | 12261879 | Malaise | |
| 122618796 | 12261879 | Melaena | |
| 122618796 | 12261879 | Neuropathy peripheral | |
| 122618796 | 12261879 | Ocular hyperaemia | |
| 122618796 | 12261879 | Paraesthesia | |
| 122618796 | 12261879 | Rhinorrhoea | |
| 122618796 | 12261879 | Somnolence | |
| 122618796 | 12261879 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122618796 | 12261879 | 1 | 20160321 | 0 | ||
| 122618796 | 12261879 | 3 | 20160321 | 0 | ||
| 122618796 | 12261879 | 6 | 20160322 | 0 | ||
| 122618796 | 12261879 | 7 | 20160322 | 0 | ||
| 122618796 | 12261879 | 8 | 20160321 | 0 |